#SuccessfulInterimAnalysis - #WhatThisMeans : John Climaco, CEO & Dr. Sandra Silberman, CMO of CNS Pharma, highlight the Company’s successful Interim Analysis results in the potentially Pivotal Study of Berubicin.
vimeo.com/896863020/647e…
$CNSP #GlioblastomaMultiforme #GBM